MedPath

A clinical study to evaluate the glycemic index (glucose level in blood in 2 Hour period) and safety of COCOZEN in Human Volunteers.

Not Applicable
Completed
Registration Number
CTRI/2018/03/012389
Lead Sponsor
Akay Flavours and Aromatics Private Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

1)Males and females in the age 18 â?? 55 years

2)Normal physical condition as determined by the investigator

3)Subject with body mass index 18.5- 27 Kg/m2 (Both inclusive)

4)Must be willing to comply with all study requirement

5)Subject should agree to avoid any kind of herbal formulations during the study period

6)Must be able and willing to provide a written informed consent.

Exclusion Criteria

1)Subject with history of cardiovascular, Type 2 Diabetes mellitus, pulmonary, hepatic and renal problems

2)Subjects who are currently under any kind of long term medication

3)Subjects with a known allergy to herbal products

4)Chronic drinkers

5)Subject with a habit of smoking

6)Subjects with abnormal biochemical or haematological values

7)Subjects with abnormal blood pressure

8)Pregnant or Lactating Women

9)Any condition that in Opinion of the Investigator, does not justify the Subjectsâ?? participation in the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Safety and tolerability assessment of COCOZEN by the measurement of hematological and Biochemical ParametersTimepoint: Day 0, Day 90
Secondary Outcome Measures
NameTimeMethod
Glycemic index of COCOZENTimepoint: Day 0, Day 2, Day 4,Day 6
© Copyright 2025. All Rights Reserved by MedPath